Drug Shortage Report for TEVA-IPRATROPIUM STERINEBS
Report ID | 198292 |
Drug Identification Number | 02216221 |
Brand name | TEVA-IPRATROPIUM STERINEBS |
Common or Proper name | TEVA-IPRATROPIUM STERINEBS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 250MCG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 10x2M |
ATC code | R03BB |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-11 |
Estimated end date | 2024-02-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-12-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-12-07 | French | Compare |
v12 | 2023-12-07 | English | Compare |
v11 | 2023-11-03 | French | Compare |
v10 | 2023-11-03 | English | Compare |
v9 | 2023-10-12 | French | Compare |
v8 | 2023-10-12 | English | Compare |
v7 | 2023-07-27 | French | Compare |
v6 | 2023-07-27 | English | Compare |
v5 | 2023-07-18 | French | Compare |
v4 | 2023-07-18 | English | Compare |
v3 | 2023-07-12 | English | Compare |
v2 | 2023-07-11 | French | Compare |
v1 | 2023-07-11 | English | Compare |
Showing 1 to 13 of 13